EMDR vs Medication for PTSD: What Has Research Found?
Eye Movement Desensitization and Reprocessing (EMDR) and medication are both used to treat Post-Traumatic Stress Disorder (PTSD), but they approach the condition in very different ways.
EMDR is a structured psychological treatment that works directly with distressing memories and their associated thoughts, emotions, and physical sensations.
Medication does not process a traumatic memory in the same way. Instead, certain medications can reduce PTSD symptoms through their effects on brain chemistry.
Research supports both psychological treatment and particular medications for PTSD. However, the evidence does not support treating EMDR and medication as interchangeable versions of the same treatment.
Major clinical guidelines generally give trauma-focused psychological treatments an important or preferred role, while also recognizing several medications as evidence-based options.
There is also surprisingly little research directly comparing EMDR with medication. One important randomized trial did exactly that, comparing EMDR with the antidepressant fluoxetine and a placebo. Its findings help illustrate both what researchers know and what remains uncertain.
Which Medications Have Been Studied for PTSD?
Many medications have been investigated for PTSD, but the evidence is not equally strong for all of them.
Some of the best-established medication evidence involves antidepressants known as selective serotonin reuptake inhibitors (SSRIs) and a related class called serotonin-norepinephrine reuptake inhibitors (SNRIs).
The 2023 US Department of Veterans Affairs and Department of Defense (VA/DoD) Clinical Practice Guideline strongly recommends three medications for PTSD:
sertraline
paroxetine
venlafaxine
Sertraline and paroxetine are SSRIs, while venlafaxine is an SNRI. The guideline found insufficient evidence to recommend for or against a number of other medications for PTSD, including fluoxetine, even though earlier research has found benefits for fluoxetine in some trials. (Health Quality)
This is an important point when discussing “medication for PTSD.” Medication is not one single treatment. Different drugs have different amounts and quality of supporting evidence.
What Does Research Show About Medication for PTSD?
Medication can reduce PTSD symptoms.
A systematic review and meta-analysis of 51 randomized controlled trials found that SSRIs produced a statistically significant reduction in PTSD symptoms compared with placebo, although the average effect was small. (PubMed)
Another large review conducted for the Agency for Healthcare Research and Quality (AHRQ) examined 92 trials of psychological and pharmacological treatments. It found evidence supporting several medications, including fluoxetine, paroxetine, sertraline, and venlafaxine.
The effects of the medications on PTSD symptoms were generally smaller than the effects found for several psychological treatments, although the researchers cautioned that there was not enough direct head-to-head evidence to determine reliably which effective treatments were superior. (PubMed)
A later network meta-analysis examined 58 studies involving 6,766 participants and 26 pharmacological interventions. Several medications, including paroxetine, venlafaxine, fluoxetine, and sertraline, performed better than placebo for PTSD symptoms. (PubMed)
Taken together, the research shows that medication can be an effective PTSD treatment, while also showing why it is important to talk about specific medications rather than medication as a single category.
What Does Research Show About EMDR?
EMDR has been studied extensively as a psychological treatment for PTSD.
In EMDR, a person brings aspects of a distressing memory to mind while engaging in bilateral stimulation, most commonly side-to-side eye movements. Treatment follows a structured process that works with the memory and its associated thoughts, emotions, beliefs, and physical sensations.
The AHRQ review found moderate-strength evidence supporting EMDR for reducing PTSD symptoms and helping some participants no longer meet diagnostic criteria for PTSD. (PubMed)
A much larger 2023 review of psychological treatments included 157 randomized controlled trials and 11,565 participants. It found that the psychological treatments studied, including EMDR and trauma-focused Cognitive Behavioral Therapy (CBT), were effective compared with control conditions.
The researchers did not find significant differences in overall efficacy among the active psychological therapies. (PubMed)
Major clinical guidelines also recognize EMDR as an evidence-supported PTSD treatment.
Has EMDR Been Compared Directly With Medication?
Yes, although there have been far fewer direct comparisons than might be expected.
One particularly important randomized clinical trial, published in 2007, compared EMDR, fluoxetine, and a pill placebo.
The study included 88 adults with PTSD. Participants received either EMDR, fluoxetine, or placebo over eight weeks. The researchers then examined both short-term treatment effects and whether improvements remained after treatment ended. (PubMed)
This study is especially useful because it did not simply compare results from unrelated EMDR and medication studies. Participants were randomized within the same trial, allowing the researchers to compare the treatments under more similar conditions.
What Did the EMDR vs Fluoxetine Trial Find?
Both EMDR and fluoxetine produced improvements compared with placebo on measures of PTSD and depression.
However, the study found important differences when researchers looked at what happened after treatment.
Six months after treatment ended, the EMDR group maintained its improvements more clearly than the fluoxetine group. The researchers reported particularly strong outcomes among participants whose PTSD followed an adult-onset trauma.
Among those participants, 91% of people who had received EMDR were asymptomatic at the six-month follow-up, compared with 72% of those who had received fluoxetine.
When the researchers used a stricter measure of complete remission, the difference was larger: 57% in the EMDR group compared with none in the fluoxetine group. (PubMed)
The results were less striking among participants whose trauma occurred during childhood. Neither treatment produced similarly high rates of complete remission in that subgroup.
These findings suggest that EMDR may have produced more durable improvement than fluoxetine in this particular study, especially among participants with adult-onset trauma.
But one trial involving 88 people is not enough to establish that EMDR is always more effective than medication.
Why Can't One Study Settle the Question?
There are several reasons.
First, the medication used in the trial was fluoxetine. It did not compare EMDR with sertraline, paroxetine, venlafaxine, or every other medication used for PTSD.
That matters because current guidelines do not treat all antidepressants as equally supported. The VA/DoD guideline, for example, strongly recommends sertraline, paroxetine, and venlafaxine but currently considers the evidence insufficient to recommend for or against fluoxetine. (Health Quality)
Second, the study included a relatively small number of participants.
Third, PTSD is not identical in everyone. The trial itself found differences according to whether trauma occurred in childhood or adulthood.
Finally, there simply have not been enough randomized trials directly comparing EMDR with established PTSD medications to make strong treatment-by-treatment conclusions.
This is a recurring problem in comparative PTSD research: we often have good evidence that two treatments work, but much less evidence from trials in which those treatments were directly tested against one another.
What Do Broader Comparisons of Psychotherapy and Medication Show?
Researchers have also tried to compare psychological treatment and medication more broadly.
A 2019 network meta-analysis examined psychological treatments, medications, and combinations of the two. The review identified only 12 randomized clinical trials involving 922 participants that allowed direct comparisons among these approaches. (PubMed)
That is a relatively small evidence base considering how commonly both psychotherapy and medication are used for PTSD.
The researchers found some evidence favoring psychological treatment over medication at follow-up, but they also emphasized the limited quantity and quality of direct comparative evidence.
Similarly, the earlier AHRQ review found strong or moderate evidence supporting several psychological therapies and several medications but concluded that there was insufficient head-to-head evidence to determine whether the effective treatments differed from one another. (PubMed)
So the research supports both categories of treatment much more confidently than it answers the question of exactly how they compare.
What Do Major PTSD Guidelines Say?
Treatment guidelines are useful here because they evaluate the broader evidence rather than relying on one study.
US Department of Veterans Affairs and Department of Defense
The US Department of Veterans Affairs and Department of Defense (VA/DoD) guideline recommends trauma-focused psychotherapy over pharmacotherapy for PTSD.
Among the individual trauma-focused psychotherapies it specifically recommends are EMDR, Cognitive Processing Therapy, and Prolonged Exposure.
For medication, the guideline strongly recommends paroxetine, sertraline, or venlafaxine. (Health Quality)
The guideline therefore recognizes both psychotherapy and medication as evidence-based PTSD treatments while giving trauma-focused psychotherapy preference when comparing the two treatment approaches.
National Institute for Health and Care Excellence
The UK National Institute for Health and Care Excellence (NICE) recommends EMDR for adults with PTSD in specified circumstances. It also recommends several forms of trauma-focused CBT.
For medication, NICE says that venlafaxine or an SSRI such as sertraline can be considered for adults with PTSD if the person prefers drug treatment.
In explaining this recommendation, NICE states that evidence supports SSRIs and venlafaxine for PTSD but that medication is not offered as the first-line treatment in its guideline.
For a broader explanation of why organizations do not always phrase their recommendations in the same way, see Why Do PTSD Guidelines Rate EMDR Differently?
Do EMDR and Medication Aim to Do the Same Thing?
Not exactly.
Medication can reduce PTSD symptoms while it is being taken. Depending on the medication, this may include changes in anxiety, mood, intrusive symptoms, sleep, or other aspects of PTSD.
EMDR directly works with distressing memories and the thoughts, feelings, sensations, and beliefs associated with them.
This difference may help explain why researchers are interested not only in symptom reduction during treatment but also in what happens after treatment ends.
The 2007 EMDR-versus-fluoxetine trial is particularly interesting for that reason. Both treatments produced improvement, but differences became more apparent during follow-up. (PubMed)
That does not mean medication benefits necessarily disappear when medication stops, nor does it mean every person completing EMDR will maintain improvement. It means durability is an important outcome when comparing different kinds of PTSD treatment.
For a closer look at this question, see Does EMDR Work Long Term? What Follow-Up Studies Show.
What About Combining Medication and Psychotherapy?
Medication and psychological treatment are not necessarily either-or choices. Some people receive both.
However, evidence about whether combining medication with trauma-focused psychotherapy consistently produces better PTSD outcomes than either approach alone is less clear than might be expected.
The comparative network meta-analysis examining psychotherapy, medication, and combined treatments found relatively few randomized trials that could answer this question reliably. (PubMed)
The available research therefore does not support a simple rule that adding medication to EMDR will necessarily improve outcomes, or that someone receiving medication would necessarily benefit more from stopping it and using psychotherapy alone.
Those are different questions from whether either treatment can work.
Does Medication Have a Larger Research Base Than EMDR?
That depends on what is being counted.
There are many randomized trials of antidepressants for PTSD, particularly SSRIs. There are also many randomized trials of EMDR and other trauma-focused psychological treatments.
But much of that research compares each treatment with a control condition rather than comparing medication directly with EMDR.
For example, a medication trial may compare sertraline with placebo, while an EMDR trial may compare EMDR with a waiting list or another psychological treatment.
Those studies can tell researchers whether each treatment works. They are less useful for answering whether EMDR works better than sertraline, for example.
This is why the amount of research supporting two treatments can be substantial while direct comparative evidence remains limited.
What Can We Reasonably Conclude?
Research supports both EMDR and certain medications as treatments for PTSD.
For medication, some of the strongest current guideline support is for sertraline, paroxetine, and venlafaxine. Research has found that these and some other antidepressants can reduce PTSD symptoms. (Health Quality)
EMDR also has substantial evidence from randomized trials and is recommended as a trauma-focused psychological treatment in major PTSD guidelines.
The limited direct research comparing EMDR with medication includes an important trial in which EMDR and fluoxetine both produced improvement, with EMDR showing stronger maintenance of some outcomes at six-month follow-up, particularly among participants with adult-onset trauma. (PubMed)
But the direct evidence is too limited to conclude that EMDR is always more effective than medication.
The broader evidence instead supports a more careful conclusion: both can help with PTSD, but they are different forms of treatment, and major guidelines generally place trauma-focused psychological treatments such as EMDR prominently—often ahead of medication—while still recognizing particular medications as evidence-based options.
Frequently Asked Questions
Is EMDR a medication-free treatment for PTSD?
Yes. Eye Movement Desensitization and Reprocessing (EMDR) is a psychological treatment rather than a medication. It uses a structured process for working with distressing memories and related thoughts, emotions, beliefs, and physical sensations.
Which medications have the strongest current guideline support for PTSD?
The 2023 US Department of Veterans Affairs and Department of Defense guideline strongly recommends sertraline, paroxetine, and venlafaxine for PTSD. Sertraline and paroxetine are selective serotonin reuptake inhibitors, while venlafaxine is a serotonin-norepinephrine reuptake inhibitor. (Health Quality)
Has EMDR been directly compared with an antidepressant?
Yes. A randomized clinical trial compared EMDR with fluoxetine and a placebo. Both active treatments produced improvement, while EMDR showed stronger maintenance of some outcomes six months after treatment, particularly among people whose trauma occurred in adulthood. (PubMed)
Do guidelines recommend EMDR or medication first?
Guidelines differ somewhat in wording, but both the US Department of Veterans Affairs and Department of Defense and the National Institute for Health and Care Excellence give trauma-focused psychological treatment an important or preferred role. Both also recognize particular medications as treatment options for adults with PTSD.
Can medication and psychological treatment be used together?
Yes, they can be used together. However, research has not clearly established that combining medication with psychological treatment consistently produces better PTSD outcomes than an effective psychotherapy alone or medication alone. Direct comparative trials remain relatively limited. (PubMed)
Conclusion
Both Eye Movement Desensitization and Reprocessing and medication have evidence supporting their use for Post-Traumatic Stress Disorder.
Certain medications—particularly sertraline, paroxetine, and venlafaxine—are supported by randomized trials and major treatment guidelines. EMDR also has a substantial research base and is recommended as a trauma-focused psychological treatment.
Direct EMDR-versus-medication research is much more limited. One randomized trial comparing EMDR with fluoxetine found improvement with both treatments and stronger maintenance of some outcomes after EMDR, but that single study cannot establish how EMDR compares with every medication used for PTSD.
What the research supports most clearly is that EMDR and medication can both reduce PTSD symptoms, while current evidence and major guidelines generally give trauma-focused psychological treatments a central or preferred role in PTSD treatment.
